“Investigators from around the world are trying to crack the nut of
cancer,” Feinstein Institute for Medical Research biologist Thomas
Rothstein, who worked for six years with the Cuban Center for Molecular
Immunology on a different vaccine for the same type of cancer, said.
“The Cubans are thinking in ways that are novel and clever.”
In Cuba, lung cancer is the fourth-leading cause of death, the
publication reveals, which explains why researchers in the region have
been looking into finding better cures for the disease.
Other countries in Europe and Japan have started clinical trials for
Cimavax, that is the name of the Cuban “cutting-edge” vaccine that’s been
25 years in the making, and which costs the Cuban government just $1 per
shot. The drug has been available as a free of charge cancer treatment since 2011 when it was released to the public.
The vaccine is very exciting for many other countries partly because
it’s cheap to mass produce and store. Furthermore, by studying Cimavax,
researchers could come up with similar therapies for other types of
cancer, something the Cuban institute has not done yet.
No comments:
Post a Comment